
Neotypica is pioneering the use of artificial intelligence to address social determinants of health in clinical trials, ensuring that underrepresented groups and emerging healthcare markets have access to breakthrough research and innovative medicines. The company provides comprehensive support to Clinical Research Organizations (CROs), academic medical centers, and life science companies through tech-enabled solutions that enhance trial efficiency, patient recruitment, and regulatory compliance. With a focus on inclusivity and collaboration, Neotypica leverages advanced technology to improve patient outcomes and streamline clinical research processes, positioning itself as a leader in the biotech industry.

Neotypica is pioneering the use of artificial intelligence to address social determinants of health in clinical trials, ensuring that underrepresented groups and emerging healthcare markets have access to breakthrough research and innovative medicines. The company provides comprehensive support to Clinical Research Organizations (CROs), academic medical centers, and life science companies through tech-enabled solutions that enhance trial efficiency, patient recruitment, and regulatory compliance. With a focus on inclusivity and collaboration, Neotypica leverages advanced technology to improve patient outcomes and streamline clinical research processes, positioning itself as a leader in the biotech industry.